Biodexa Pharmaceuticals (BDRX) Announces ADR Ratio Change
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
ADR Ratio Change
September 19, 2024 4:30 PM EDTSeptember 19, 2024
Biodexa Pharmaceuticals PLC
(Biodexa or the Company)
ADR Ratio Change
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announces a ratio change on its American Depositary Receipts (ADR) from one (1) ADR representing four hundred (400) ordinary shares, to the new ratio of one (1) ADR representing ten thousand (10,000) ordinary shares (the "Ratio Change"). The effective date of the... More
